Literature DB >> 29600060

Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Masaki Hashimoto1, Fumihiro Tanaka2, Kazue Yoneda2, Teruhisa Takuwa1, Seiji Matsumoto1, Yoshitomo Okumura3, Nobuyuki Kondo1, Tohru Tsujimura4, Takashi Nakano5, Seiki Hasegawa1.   

Abstract

BACKGROUND: In non-small cell lung cancer (NSCLC), circulating tumor cells (CTC) are shed and circulate to the peripheral blood through the pulmonary vein. Previously, CTC count in pulmonary venous blood (pvCTC) was shown to significantly increase after surgical manipulation. Therefore, we assessed the correlation between the changes in the pvCTC count (ΔpvCTC) and clinical outcomes.
METHODS: Consecutive patients with peripheral-type, NSCLC, who underwent lobectomy or bi-lobectomy through open thoracotomy, were enrolled prospectively. Before and after lobectomy, 2.5 mL of blood was drawn from the associated lobar pulmonary vein (PV), and was served for the quantitative evaluation of CTC using the CellSearch® system. The cut-off point of ΔpvCTC was determined according to clinical outcomes and ΔpvCTC using receiver operation characteristic (ROC) curve. Then the correlation between ΔpvCTC and clinical outcomes was evaluated by Kaplan-Meier analyses and log-rank test. In addition, the correlation between ΔpvCTC and perioperative variables was assessed.
RESULTS: A total of 30 patients were enrolled, tumor recurrence occurred in 11 patients over a median follow-up of 64.4 months. Of these, 7 patients had distant metastasis and 4 had local recurrence. The median ΔpvCTC was 49 cells/2.5 mL, and pvCTC-count was increased during surgical manipulation in 24 patients (80%). We divided patients into two groups based on ΔpvCTC with the cut-off value as 119 cells/2.5 mL according to ROC curve. Significant shorter time to distant metastasis (TDM) (P=0.0123) was observed in high ΔpvCTC group (ΔpvCTC ≥119 cells/2.5 mL) than low ΔpvCTC group (ΔpvCTC <119 cells/ 2.5mL). Neither disease-free survival (DFS) nor overall survival (OS) was significantly correlated with ΔpvCTC.
CONCLUSIONS: Increasing pvCTC count during surgical manipulation was significantly correlated with postoperative distant metastasis in completely resected NSCLC patients. Significant shorter TDM was observed in patient with high ΔpvCTC group.

Entities:  

Keywords:  Circulating tumor cells (CTCs); non-small cell lung cancer (NSCLC); surgical manipulation

Year:  2018        PMID: 29600060      PMCID: PMC5863181          DOI: 10.21037/jtd.2017.12.56

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  Avoidable vascular spread in resection for bronchial carcinoma.

Authors:  J A AYLWIN
Journal:  Thorax       Date:  1951-09       Impact factor: 9.139

2.  Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer.

Authors:  Luis Resel Folkersma; Luis San José Manso; Isabel Galante Romo; Jesüs Moreno Sierra; Carlos Olivier Gómez
Journal:  Urology       Date:  2012-10-10       Impact factor: 2.649

3.  Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact.

Authors:  Kenji Suzuki; Masahiko Kusumoto; Shun-ichi Watanabe; Ryosuke Tsuchiya; Hisao Asamura
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

4.  Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Takuo Hayashi; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  J Thorac Oncol       Date:  2017-02-28       Impact factor: 15.609

5.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

6.  Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?

Authors:  Noriyoshi Sawabata; Soichiro Funaki; Takeru Hyakutake; Yasushi Shintani; Ayako Fujiwara; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-03-07       Impact factor: 2.549

7.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Authors:  Steven J Cohen; Cornelis J A Punt; Nicholas Iannotti; Bruce H Saidman; Kert D Sabbath; Nashat Y Gabrail; Joel Picus; Michael Morse; Edith Mitchell; M Craig Miller; Gerald V Doyle; Henk Tissing; Leon W M M Terstappen; Neal J Meropol
Journal:  J Clin Oncol       Date:  2008-07-01       Impact factor: 44.544

8.  Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance.

Authors:  Wulf Sienel; Rita Seen-Hibler; Wolf Mutschler; Klaus Pantel; Bernward Passlick
Journal:  Eur J Cardiothorac Surg       Date:  2003-04       Impact factor: 4.191

9.  Significance of tumour vessel invasion in determining the morphology of isolated tumour cells in the pulmonary vein in non-small-cell lung cancer.

Authors:  Soichiro Funaki; Noriyoshi Sawabata; Abulimiti Abulaiti; Tomoyuki Nakagiri; Yasushi Shintani; Masayoshi Inoue; Masato Minami; Meinoshin Okumura
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-25       Impact factor: 4.191

10.  Effects of different sequences of pulmonary artery and vein ligations during pulmonary lobectomy on blood micrometastasis of non-small cell lung cancer.

Authors:  Ping-Ping Song; Weidi Zhang; Baijiang Zhang; Qi Liu; Jiajun DU
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

View more
  14 in total

1.  Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?

Authors:  Noriyoshi Sawabata; Toshitaka Nakamura; Takeshi Kawaguchi; Takashi Watanabe; Noriko Sageshima Ouji; Toshihiro Ito; Shigeki Taniguchi
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

2.  Wedge Resection of Tumor Before Lobectomy for Lung Cancer Could Be a No-touch Isolation Technique.

Authors:  Motoaki Yasukawa; Noriyoshi Sawabata; Takeshi Kawaguchi; Shigeki Taniguchi
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

3.  Association between different sequences of vessel ligation during video-assisted thoracoscopic lobectomy and survival in patients with non-small cell lung cancer.

Authors:  Huang-He He; Jia-Xi He; Zhe-Xue Hao; Wei Wang; Jian-Xing He
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

4.  Prognostic Role of Circulating Tumor Cells in the Pulmonary Vein, Peripheral Blood, and Bone Marrow in Resectable Non-Small Cell Lung Cancer.

Authors:  Jeong Moon Lee; Woohyun Jung; Sungwon Yum; Jeong Hoon Lee; Sukki Cho
Journal:  J Chest Surg       Date:  2022-06-05

Review 5.  Possible role of circulating tumor cells in early detection of lung cancer.

Authors:  Cristina Poggiana; Elisabetta Rossi; Rita Zamarchi
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 3.005

6.  Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study.

Authors:  Xinchun Duan; Yujie Zhu; Yong Cui; Zhenrong Yang; Shijie Zhou; Yi Han; Daping Yu; Ning Xiao; Xiaoqing Cao; Yunsong Li; Shuku Liu; Zitong Wang; Wen Zhang; Lin Feng; Kaitai Zhang; Jianzhong Shou; Zhidong Liu; Shaofa Xu
Journal:  Thorac Cancer       Date:  2018-12-04       Impact factor: 3.500

7.  Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells.

Authors:  Zujun Que; Zhiyi Zhou; Bin Luo; Changsheng Dong; Yi Jiang; Hegen Li; Jianhui Tian
Journal:  BMC Complement Altern Med       Date:  2019-08-07       Impact factor: 3.659

Review 8.  Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells.

Authors:  Etienne Buscail; Laurence Chiche; Christophe Laurent; Véronique Vendrely; Quentin Denost; Jérôme Denis; Matthieu Thumerel; Jean-Marc Lacorte; Aurélie Bedel; François Moreau-Gaudry; Sandrine Dabernat; Catherine Alix-Panabières
Journal:  Mol Oncol       Date:  2019-07-25       Impact factor: 6.603

9.  The essential role of PRAK in tumor metastasis and its therapeutic potential.

Authors:  Yuqing Wang; Wei Wang; Haoming Wu; Yu Zhou; Xiaodan Qin; Yan Wang; Jia Wu; Xiu-Yuan Sun; Yan Yang; Hui Xu; Xiaoping Qian; Xuewen Pang; Yan Li; Zhiqian Zhang; Jiahuai Han; Yu Zhang
Journal:  Nat Commun       Date:  2021-03-19       Impact factor: 14.919

10.  Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.

Authors:  Mio Ikeda; Yasuhiro Koh; Shunsuke Teraoka; Koichi Sato; Jun Oyanagi; Atsushi Hayata; Nahomi Tokudome; Hiroaki Akamatsu; Yuichi Ozawa; Katsuya Endo; Masayuki Higuchi; Masanori Nakanishi; Hiroki Ueda; Nobuyuki Yamamoto
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.